Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia L Stuani, M Sabatier, E Saland, G Cognet, N Poupin, C Bosc, FA Castelli, ... Journal of Experimental Medicine 218 (5), e20200924, 2021 | 91 | 2021 |
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia C Bosc, E Saland, A Bousard, N Gadaud, M Sabatier, G Cognet, T Farge, ... Nature cancer 2 (11), 1204-1223, 2021 | 78 | 2021 |
Extracellular ATP and CD39 activate cAMP-mediated mitochondrial stress response to promote cytarabine resistance in acute myeloid leukemia N Aroua, E Boet, M Ghisi, ML Nicolau-Travers, E Saland, R Gwilliam, ... Cancer Discovery 10 (10), 1544-1565, 2020 | 72 | 2020 |
Stable isotope labeling highlights enhanced fatty acid and lipid metabolism in human acute myeloid leukemia L Stuani, F Riols, P Millard, M Sabatier, A Batut, E Saland, F Viars, ... International Journal of Molecular Sciences 19 (11), 3325, 2018 | 65 | 2018 |
Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in human acute myeloid leukemia M Hosseini, HR Rezvani, N Aroua, C Bosc, T Farge, E Saland, ... Cancer Research 79 (20), 5191-5203, 2019 | 64 | 2019 |
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia L Stuani, M Sabatier, JE Sarry BMC biology 17 (1), 57, 2019 | 57 | 2019 |
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells C Larrue, N Guiraud, PL Mouchel, M Dubois, T Farge, M Gotanègre, ... Nature communications 12 (1), 422, 2021 | 51 | 2021 |
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3-Mutant Leukemia M Sabatier, R Birsen, L Lauture, S Mouche, P Angelino, J Dehairs, ... Cancer Discovery 13 (7), 1720-1747, 2023 | 47 | 2023 |
Emerging metabolomic tools to study cancer metastasis LMN Melo, NP Lesner, M Sabatier, JM Ubellacker, A Tasdogan Trends in Cancer 8 (12), 988-1001, 2022 | 38 | 2022 |
CD36 drives metastasis and relapse in acute myeloid leukemia T Farge, J Nakhle, D Lagarde, G Cognet, N Polley, R Castellano, ... Cancer Research 83 (17), 2824-2838, 2023 | 33 | 2023 |
Activation of vitamin D receptor pathway enhances differentiating capacity in acute myeloid leukemia with isocitrate dehydrogenase mutations M Sabatier, E Boet, S Zaghdoudi, N Guiraud, A Hucteau, N Polley, ... Cancers 13 (20), 5243, 2021 | 11 | 2021 |
Activation of lysosomal iron triggers ferroptosis in cancer R Rodriguez, T Cañeque, L Baron, S Müller, A Carmona, L Colombeau, ... Research Square, 2024 | 5 | 2024 |
C/EBPα confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress in FLT3-mutant leukemia M Sabatier, R Birsen, L Lauture, J Dehairs, P Angelino, S Mouche, ... bioRxiv, 2022.04. 15.488522, 2022 | 2 | 2022 |
Mitochondrial determinants of response and resistance to venetoclax plus cytarabine duplet therapy in acute myeloid leukemia C Bosc, N Gadaud, A Bousard, M Sabatier, G Cognet, E Saland, T Farge, ... BioRxiv, 2020.08. 17.253856, 2020 | 2 | 2020 |
Combinatory therapy targeting mitochondrial oxidative phosphorylation improves efficacy of IDH mutant inhibitors in acute myeloid leukemia L Stuani, M Sabatier, F Wang, N Poupin, C Bosc, E Saland, F Castelli, ... bioRxiv, 749580, 2019 | 1 | 2019 |
Lymphatic collection and cell isolation from mouse models for multiomic profiling M Sabatier, A Solanki, S Thangaswamy, P Lei, H Zhou, M O’Melia, ... Nature Protocols, 1-18, 2025 | | 2025 |
Selenoprotein O Promotes Melanoma Metastasis and Regulates Mitochondrial Complex II Activity LM Nascentes Melo, M Sabatier, V Ramesh, KJ Szylo, CS Fraser, A Pon, ... Cancer Research, 2024 | | 2024 |
Precision diet and lipid modulating agents to induce lipid oxidation in breast cancer M Yavari, J Torpey, M Sabatier, A Carmona, K Szylo, M Flores, M Palma, ... Cancer Research 84 (6_Supplement), 430-430, 2024 | | 2024 |
Selenoprotein O regulates melanoma metastasis through mitochondrial complex II activity L Melo, M Nascentes, M Sabatier, V Ramesh, A Pon, KJ Szylo, ... EXPERIMENTAL DERMATOLOGY 33 (3), 2024 | | 2024 |
Abstract A24: Targeting mitochondrial metabolism following Induction Chemotherapy eradicates Acute Myeloid Leukemia at the level of Minimal Residual Disease N Baran, L Han, L Stuani, A Cavazos, LM Cooper, CL Ramage, ... Blood Cancer Discovery 4 (3_Supplement), A24-A24, 2023 | | 2023 |